ShanghaiTech University Knowledge Management System
| Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment | |
| 2023-05 | |
| 发表期刊 | SIGNAL TRANSDUCTION AND TARGETED THERAPY (IF:40.8[JCR-2023],40.5[5-Year]) |
| ISSN | 2059-3635 |
| 发表状态 | 已发表 |
| DOI | 10.1038/s41392-023-01482-9 |
| 收录类别 | SCI |
| 引用统计 | 正在获取...
|
| 文献类型 | 期刊论文 |
| 条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/345986 |
| 专题 | 生命科学与技术学院_博士生 生命科学与技术学院 |
| 共同第一作者 | Bo Feng; Yumin Zhang; Tianqing Nie |
| 通讯作者 | Haixia Su; Leike Zhang; Yi Zang; Yu Zhou |
| 作者单位 | 1.School of Life Science and Technology，ShanghaiTech University, Shanghai 201203, China 2.Lingang Laboratory，Shanghai 201203，China 3.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China 4.Shenyang Pharmaceutical University, Shenyang 110016, China 5.State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety MegaScience, Chinese Academy of Sciences, Wuhan 430071, China |
| 第一作者单位 | 生命科学与技术学院 |
| 通讯作者单位 | 生命科学与技术学院 |
| 第一作者的第一单位 | 生命科学与技术学院 |
| 推荐引用方式 GB/T 7714 | Zhidong Jiang,Bo Feng,Yumin Zhang,et al. Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2023. |
| APA | Zhidong Jiang.,Bo Feng.,Yumin Zhang.,Tianqing Nie.,Hong Liu.,...&Yu Zhou.(2023).Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment.SIGNAL TRANSDUCTION AND TARGETED THERAPY. |
| MLA | Zhidong Jiang,et al."Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment".SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023). |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
修改评论
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。